The submitted project is about models for the development of new therapeutic options for cancer treatment. Every two years, the association Ärzte gegen Tierversuche e.V. (Doctors Against Animal Experi
$60M program focusing on Dynamic Resilience from Wellcome Leap and Temasek Trust funds international research group led by Tübingen professor Dynamic resilience, the ability of humans to withstand une
More than seven million people in Germany suffer from diabetes. Drug research is still difficult. Scientists led by Peter Loskill from the NMI and the University of Tübingen have developed a technique
Does our therapeutic approach work against cancer? A planned NMI spin-off has developed a technology that shall answer this question more quickly - and thus save valuable time for patients and money f
Heal-X Bioink: The new chapter in 3D bioprinting begins! Today saw the much-anticipated kick-off of the BMBF-funded Heal-X Bioink project, which focuses on the development of a self-healing, bio-inspi
CAR-T cells are expected to revolutionize cancer therapy. CAR-T cells are expected to revolutionize cancer therapy. In order to obtain these helpers in the future more cost-effectively than before and
Dr. Dagmar Martin in an interview. Why are surfaces so important in medical technology and what challenges await us? Take a look at the exciting interview by microTEC Südwest e.V. on the work of Dr. D
For the implementation of personalized oncology, it is crucial to develop tumor models that allow individualized validation of cancer therapies that are particularly effective in each case. For the im
After 4 years it was finally time again - the NMI in Reutlingen invited the network of microelectrode array (MEA) developers and users to Tübingen for the MEA Conference 2022. After 4 years it was fin
Dr. Markus Templin - Early detection of skin cancer The 72nd Lindau Nobel Laureate Meeting #LINO23, dedicated to the theme of physiology/medicine, was held from June 25-30, 2023. 38 Nobel Laureates an